Recent Research
2012 Study: Effects of PectaSol and Doxorubin in Prostate Cancer Cells
2011 UK Kidney Study: Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity
2011 Study: PectaSol-C Modified Citrus Pectin Activates Powerful Immune Response
2010 Columbia University Study: PectaSol-C Modified Citrus Pectin Fights Prostate Cancer
2010 Review: Modified Citrus Pectin Anti-metastatic Properties
2009 UK Study: Modified Citrus Pectin Binding to Galectin-3
Past Research
2007 Study: The role of Modified Citrus Pectin/alginates in heavy metal chelation and detoxification
2007 German Study: Modified Citrus Pectin Clinical Benefit in Patients with Advanced Solid Tumors
2006 Study: The effect of modified citrus pectin on the urinary excretion of toxic elements.
2005 Study: Examines Citrus Pectin Induced Apoptosis in Multiple Myeloma Cells
2003 Study: Modified Citrus Pectin Increases PSA Doubling Time in Prostate Cancer
Early Research
2000 Study: Quercetin and Modified Citrus Pectin with Colon Cancer
1995 Study: Changes in Prostate Cells Growth with Modified Citrus Pectin
1995 Study: Modified Citrus Pectin and Prostate Cancer
1994 Study: Modified Citrus Pectin with Melanoma and Galectin-3
1992 Study: Modified Citrus Pectin and Prostate Cancer and Lung Metastasis of Melanoma Cells